Questions discussed in this category
Patient is undergoing RT and has already started on a GnRH antagonist. If so, how long after their last fraction would be an appropriate wait time?
Does your practice differ depending on the disease site?
Most patients with PGNMID have no detectable disease in their marrow or blood and urine protein cannot adequately be monitored.
257251534119490210411809414834
Papers discussed in this category
Transplantation reviews (Orlando, Fla.), 2021 Jun 24
Oncology research, 2018-04-10
Balkan journal of medical genetics : BJMG, 2023 May 02
Kidney international, 2018-07
BMC nephrology, 2019-02-14
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2020 Oct 23